Comparison of the efficacy and risk of therapy with the vitamin K antagonist Phenprocoumon with new oral anticoagulants in catheter ablation of atrial fibrillation
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
In: Erschienen als Manuscript in European Heart Journal Open, 2023 Jun (20)
Tübingen, Universität Tübingen, Dissertation, 2023
- Keyword
-
Vorhofflimmern
Schlaganfall
Hochfrequenz-Katheterablation
Prävention
- Event
-
Veröffentlichung
- (where)
-
Tübingen
- (who)
-
Universitätsbibliothek Tübingen
- (when)
-
2023
- Creator
-
Gjermeni, Diona
- Contributor
-
Külkamp, Volker
- URN
-
urn:nbn:de:bsz:21-dspace-1437080
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:48 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Gjermeni, Diona
- Külkamp, Volker
- Universitätsbibliothek Tübingen
Time of origin
- 2023
Other Objects (12)
Comparison of phenprocoumon with direct oral anticoagulants in catheter ablation of atrial fibrillation
Vitamin-K-antagonist phenprocoumon versus low-dose direct oral anticoagulants (DOACs) in patients with atrial fibrillation: a real-world analysis of German claims data
Vitamin-K-antagonist phenprocoumon versus low-dose direct oral anticoagulants (DOACs) in patients with atrial fibrillation: a real-world analysis of German claims data
Underutilization of anticoagulants in patients with nonvalvular atrial fibrillation in the era of non-vitamin K antagonist oral anticoagulants
Non-vitamin K antagonist oral anticoagulants in patients with an increased risk of bleeding
Use of Non-Vitamin K Antagonist Oral Anticoagulants Among Patients with Nonvalvular Atrial Fibrillation and Multimorbidity
The Importance of Appropriate Dosing of Nonvitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Patients with Atrial Fibrillation
Inappropriate non-vitamin K antagonist oral anticoagulants prescriptions: be cautious with dose reductions
Effectiveness and safety of non-vitamin K antagonist oral anticoagulants in low-weight patients with atrial fibrillation
The efficacy and safety of direct oral anticoagulants compared with vitamin K antagonist in patients with hypertrophic cardiomyopathy and atrial fibrillation
The Impact of Polypharmacy on the Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation
Use of Anticoagulants in Patients with Pulmonary Hypertension
Comparison of phenprocoumon with direct oral anticoagulants in catheter ablation of atrial fibrillation
Vitamin-K-antagonist phenprocoumon versus low-dose direct oral anticoagulants (DOACs) in patients with atrial fibrillation: a real-world analysis of German claims data
Vitamin-K-antagonist phenprocoumon versus low-dose direct oral anticoagulants (DOACs) in patients with atrial fibrillation: a real-world analysis of German claims data
Underutilization of anticoagulants in patients with nonvalvular atrial fibrillation in the era of non-vitamin K antagonist oral anticoagulants
Non-vitamin K antagonist oral anticoagulants in patients with an increased risk of bleeding
Use of Non-Vitamin K Antagonist Oral Anticoagulants Among Patients with Nonvalvular Atrial Fibrillation and Multimorbidity
The Importance of Appropriate Dosing of Nonvitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Patients with Atrial Fibrillation
Inappropriate non-vitamin K antagonist oral anticoagulants prescriptions: be cautious with dose reductions
Effectiveness and safety of non-vitamin K antagonist oral anticoagulants in low-weight patients with atrial fibrillation
The efficacy and safety of direct oral anticoagulants compared with vitamin K antagonist in patients with hypertrophic cardiomyopathy and atrial fibrillation
The Impact of Polypharmacy on the Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation
Use of Anticoagulants in Patients with Pulmonary Hypertension
Comparison of phenprocoumon with direct oral anticoagulants in catheter ablation of atrial fibrillation
Vitamin-K-antagonist phenprocoumon versus low-dose direct oral anticoagulants (DOACs) in patients with atrial fibrillation: a real-world analysis of German claims data
Vitamin-K-antagonist phenprocoumon versus low-dose direct oral anticoagulants (DOACs) in patients with atrial fibrillation: a real-world analysis of German claims data
Underutilization of anticoagulants in patients with nonvalvular atrial fibrillation in the era of non-vitamin K antagonist oral anticoagulants
Non-vitamin K antagonist oral anticoagulants in patients with an increased risk of bleeding
Use of Non-Vitamin K Antagonist Oral Anticoagulants Among Patients with Nonvalvular Atrial Fibrillation and Multimorbidity
The Importance of Appropriate Dosing of Nonvitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Patients with Atrial Fibrillation
Inappropriate non-vitamin K antagonist oral anticoagulants prescriptions: be cautious with dose reductions
Effectiveness and safety of non-vitamin K antagonist oral anticoagulants in low-weight patients with atrial fibrillation
The efficacy and safety of direct oral anticoagulants compared with vitamin K antagonist in patients with hypertrophic cardiomyopathy and atrial fibrillation
The Impact of Polypharmacy on the Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation